D. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global Cancer Statistics, 2002, Global cancer statistics, pp.74-108, 2002.
DOI : 10.3322/canjclin.55.2.74

A. Jemal, R. Siegel, and E. Ward, Cancer Statistics, 2008, CA: A Cancer Journal for Clinicians, vol.58, issue.2, pp.71-96, 2008.
DOI : 10.3322/CA.2007.0010

A. Morrison, Advances in the etiology of urothelial cancer, Urol Clin North Am, vol.11, pp.557-66, 1984.

M. Gelfand, R. Weinberg, and W. Castle, Relation between carcinoma of the bladder and infestation with Schistosoma haematobium, Lancet, vol.1, pp.1249-51, 1967.

B. Pesch, J. Haerting, U. Ranft, A. Klimpel, B. Oelschlagel et al., Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany, International Journal of Epidemiology, vol.29, issue.6, pp.1014-1038, 2000.
DOI : 10.1093/ije/29.6.1014

C. Tremblay, B. Armstrong, G. Theriault, and J. Brodeur, Estimation of risk of developing bladder cancer among workers exposed to coal tar pitch volatiles in the primary aluminum industry, American Journal of Industrial Medicine, vol.61, issue.3, pp.335-383, 1995.
DOI : 10.1002/ajim.4700270303

M. Kogevinas, A. Mannetje, and S. Cordier, Occupation and bladder cancer among men in Western Europe, Cancer Causes & Control, vol.14, issue.10, pp.907-921, 2003.
DOI : 10.1023/B:CACO.0000007962.19066.9c

J. Van-rooij, M. Veeger, M. Bodelier-bade, P. Scheepers, and F. Jongeneelen, Smoking and dietary intake of polycyclic aromatic hydrocarbons as sources of interindividual variability in the baseline excretion of 1-hydroxypyrene in urine, International Archives of Occupational and Environmental Health, vol.113, issue.Suppl 3, pp.55-65, 1994.
DOI : 10.1007/BF00386580

P. Boffetta, N. Jourenkova, and P. Gustavsson, Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons, Cancer Causes and Control, vol.8, issue.3, pp.444-72, 1997.
DOI : 10.1023/A:1018465507029

P. Simioli, S. Lupi, and P. Gregorio, Non-smoking coke oven workers show an occupational PAH exposure-related increase in urinary mutagens, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol.562, issue.1-2, pp.103-113, 2004.
DOI : 10.1016/j.mrgentox.2004.05.009

J. Spinelli, P. Demers, and N. Le, Cancer risk in aluminum reduction plant workers (Canada), Cancer Causes & Control, vol.50, issue.12, pp.939-987, 2006.
DOI : 10.1007/s10552-006-0031-9

M. Cosman, C. De-los-santos, and R. Fiala, Solution conformation of the major adduct between the carcinogen (+)-anti-benzo[a]pyrene diol epoxide and DNA., Proceedings of the National Academy of Sciences, vol.89, issue.5, pp.1914-1922, 1992.
DOI : 10.1073/pnas.89.5.1914

H. Bartsch, DNA Adducts in Human Carcinogenesis, Mutat Res, vol.340, pp.67-79, 1996.
DOI : 10.1007/978-94-011-5165-8_24

L. Koss, Bladder cancer from a perspective of 40 years, J Cell Biochem, vol.16, pp.23-32, 1992.

R. Lee and M. Droller, THE NATURAL HISTORY OF BLADDER CANCER, Urologic Clinics of North America, vol.27, issue.1, pp.1-13, 2000.
DOI : 10.1016/S0094-0143(05)70229-9

C. Billerey, D. Chopin, and M. Aubriot-lorton, Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) Tumors, The American Journal of Pathology, vol.158, issue.6, pp.1955-1964, 2001.
DOI : 10.1016/S0002-9440(10)64665-2

C. Spruck, P. Ohneseit, and M. Gonzalez-zulueta, Two molecular pathways to transitional cell carcinoma of the bladder, Cancer Res, vol.54, pp.784-792, 1994.

M. Naski, Q. Wang, J. Xu, and D. Ornitz, Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia, Nature Genetics, vol.84, issue.2, pp.233-240, 1996.
DOI : 10.1038/ng0696-233

M. Webster and D. Donoghue, FGFR activation in skeletal disorders: Too much of a good thing, Trends in Genetics, vol.13, issue.5, pp.178-82, 1997.
DOI : 10.1016/S0168-9525(97)01131-1

I. Bernard-pierrot, A. Brams, and C. Dunois-larde, Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b, Carcinogenesis, vol.27, issue.4, pp.740-747, 2006.
DOI : 10.1093/carcin/bgi290

H. Wallerand, A. Bakkar, and S. De-medina, Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens, Carcinogenesis, vol.26, issue.1, pp.177-84, 2005.
DOI : 10.1093/carcin/bgh275

S. Johansson and C. Busch, Papillary urothelial neoplasm of low malignant potential

J. N. Eble, G. S. Jonathan, I. Epstein, &. Isabelle, and A. Sesterhenn, Tumors of the urinary system and male genital organs, World health organisation classification of tumors, pp.115-122, 2004.

V. Reuter, . Non-invasive, . High-grade, . N. John, G. S. Eble et al., Tumors of the urinary system and male genital organs, World health organisation classification of tumors, pp.117-125, 2004.

M. Babjuk, W. Oosterlinck, and R. Sylvester, EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, European Urology, vol.54, issue.2, pp.303-317, 2008.
DOI : 10.1016/j.eururo.2008.04.051

J. Van-oers, I. Lurkin, and A. Van-exsel, A Simple and Fast Method for the Simultaneous Detection of Nine Fibroblast Growth Factor Receptor 3 Mutations in Bladder Cancer and Voided Urine, Clinical Cancer Research, vol.11, issue.21, pp.7743-7751, 2005.
DOI : 10.1158/1078-0432.CCR-05-1045

T. Martone, L. Airoldi, and C. Magagnotti, 4-aminobiphenyl-DNA adducts and p53 mutations in bladder cancer, International Journal of Cancer, vol.86, issue.4, pp.512-518, 1998.
DOI : 10.1002/(SICI)1097-0215(19980209)75:4<512::AID-IJC4>3.0.CO;2-W

G. Talaska, M. Schamer, and P. Skipper, Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity, Cancer Epidemiol Biomarkers Prev, vol.1, pp.61-67, 1991.

T. Hsu, Y. Zhang, and R. Santella, Immunoperoxidase quantitation of 4- aminobiphenyl-and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Polynuclear Aromatic Compounds, part 1 : Chemical, Environmental and Experimental data, Cancer Epidemiol Biomarkers Prev IARC, vol.6, issue.32, pp.193-202, 1983.

M. Woenckhaus, L. Klein-hitpass, and U. Grepmeier, Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers, The Journal of Pathology, vol.59, issue.2, pp.192-204, 2006.
DOI : 10.1002/path.2039

M. Woenckhaus, J. Merk, and R. Stoehr, Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-???small cell lung cancer, Human Pathology, vol.39, issue.1, pp.126-162, 2008.
DOI : 10.1016/j.humpath.2007.05.027

D. Brooks, A. Geller, J. Chang, and D. Miller, Occupation, smoking, and the risk of high-grade invasive bladder cancer in Missouri, American Journal of Industrial Medicine, vol.114, issue.5, pp.699-713, 1992.
DOI : 10.1002/ajim.4700210510

A. Hazra, H. Grossman, Y. Zhu, S. Luo, M. Spitz et al., Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer, Genes, Chromosomes and Cancer, vol.102, issue.4, pp.330-338, 2004.
DOI : 10.1002/gcc.20093

C. Marsit, M. Karagas, and H. Danaee, Carcinogen exposure and gene promoter hypermethylation in bladder cancer, Carcinogenesis, vol.27, issue.1, pp.112-118, 2006.
DOI : 10.1093/carcin/bgi172